Aussie Pharma (API AU): Wesfarmer's Sweetened (Yet Indicative) Offer
Trading at a 5.8%/15.8% gross/annualised spread, assuming mid-Feb completion. But it's not a super liquid arb situation. Plus this remains a non...
417 Views
Wesfarmers’ Revised Bid for API Gains Due Diligence Access
The revised indicative offer of A$1.55 per share is fair. At the last close price of A$1.48, the shares are trading at a 4.7% gross spread to the...
246 Views
API AU: The Hunter Turns The Hunted As Wesfarmers Makes A Move
With SOL's backing, you realistically have a $1.38/share floor, with the possibility of another bidder emerging. You could position yourself around...
320 Views
Last Week in GER Research: Navitas, Mindtree, PG&E, Delta Electronics, GDS, Myob, Sigma and Ruhnn
Below is a recap of the key Event-driven, IPO and placement research produced by the Global Equity Research team. This week we highlight Arun's...
470 Views
Aveo: Take Advantage of the Lull To Take a Second Crack
Back in August, I argued a case for the privatisation of Aveo Group (AOG AU), which at the time was trading at a P/B of 0.6x versus ~2x for peers....
668 Views